News Articles for "Humira"
Drugmaker AbbVie rises following analyst upgrade
Shares of drugmaker AbbVie Inc. rose to its highest point Monday after a Morgan Stanley analyst upgraded the stock, expecting greater sales of the Chicago...
read more
Rigel slumps on rheumatoid arthritis drug results
Shares of Rigel Therapeutics Inc. lost more than a third of their value Friday on mixed results from a late-stage clinical trial of a rheumatoid arthritis...
read more
Abbvie sets first annual guidance after spinoff
Abbvie Inc., the pharmaceutical spinoff of Abbott Laboratories, issued its first annual guidance Wednesday, straddling Wall Street estimates. On Jan. 1 Ab...
read more-
Lilly ends 1 trial of rheumatoid arthritis drug
Eli Lilly & Co. said Thursday that it stopped one late-stage trial of its experimental drug tabalumab as a treatment for rheumatoid arthritis. Lilly said ...
read more